Karen Pendergrass

Karen Pendergrass, Standards Team

About

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.

Recent Posts

2025-07-07

Ureaplasma urealyticum (U. urealyticum)

Ureaplasma urealyticum is a wall-less, urease-producing pathobiont of the urogenital tract linked to infertility, preterm birth, and neonatal lung disease. Its virulence stems from nickel-dependent urease activity, immune-evasive antigens, and proinflammatory lipoproteins.

2025-07-07

Streptococcus spp.

Streptococcus is a genus of gram-positive, facultatively anaerobic bacteria commonly found in pairs or chains. Important human pathogens include Streptococcus pneumoniae, Streptococcus pyogenes (group A strep), and Streptococcus agalactiae (group B strep).

2025-07-07

Streptococcus agalactiae (GBS)

Streptococcus agalactiae, also known as Group B Streptococcus (GBS), is a Gram-positive, facultative anaerobe commonly found as a commensal organism in the gastrointestinal and urogenital tracts of humans. While asymptomatic colonization is frequent, GBS is also a major pathogen, particularly in neonates, pregnant women, and immunocompromised individuals.

2025-07-07

H pylori

OverviewHelicobacter pylori, a bacterium that colonizes the human stomach, is primarily known for its pathogenic role, particularly in causing peptic ulcers, chronic gastritis, and its association with gastric cancer. However, research has also suggested that H. pylori infection may have protective roles against other diseases. The concept of H. pylori exerting protective effects against certain […]

2025-07-07

Microbiome Diet for Endometriosis

OverviewEndometriosis is a chronic, inflammatory condition affecting approximately 10% of women of reproductive age, marked by debilitating and chronic pelvic pain, infertility, and systemic inflammation. Emerging research reveals that endometriosis is closely linked to disruptions in the gut microbiome, with cross-signature overlap with irritable bowel syndrome (IBS), highlighting the potential of targeted dietary interventions to […]

2025-07-07

Endometriosis Guide

Overview The constant bi-directional communication between microbiota and the host signifies the microbiome’s crucial role in health complications and its potential in healthcare advancements. This discussion sets the stage for exploring the microbiome’s anticipated contributions to modern medicine, particularly in addressing conditions such as endometriosis (EMS), which affects approximately 200 million individuals globally. Despite centuries […]

2025-07-07

Flavones and Flavonols

Flavones and flavonols are plant-derived compounds known for their antioxidant, anti-inflammatory, and antimicrobial properties.

2025-07-07

Infertility

Infertility is the inability to conceive after 12 months of regular, unprotected sex. It affects both men and women and can be due to various physical, hormonal, or genetic factors. Treatments include medication, surgery, assisted reproductive technologies, and lifestyle changes.

2025-07-07

Chronic Pelvic Pain (CPP)

Chronic Pelvic Pain (CPP) is persistent pain in the pelvic region lasting six months or longer, often multifactorial, impacting physical and emotional well-being, and associated with various medical conditions.

2025-07-07

Anemia

Anemia is a reduction in red blood cells or hemoglobin, often influenced by the gut microbiome’s impact on nutrient absorption.

2025-07-07

Our Validation Method

Our validation method employs a systematic, data-driven approach to confirm the reliability of microbiome signatures and the efficacy of microbiome-targeted interventions (MBTIs). The process integrates comprehensive meta-analysis, machine learning-driven microbial association detection, and cross-referenced therapeutic validation, ensuring both precision and translational applicability. Validation Workflow 1. Microbiome Signature Identification A condition’s microbiome signature is established through […]

2025-07-07

Microbiome Signature Confidence Score (MSCS): A Quantitative Framework

Overview In the ever-expanding field of microbiome research, one of the most important and contentious challenges is identifying what truly constitutes a microbiome signature for a given condition. Is it the presence of Akkermansia muciniphila in a few case reports? Is it a meta-analysis conclusion drawn from heterogeneously designed studies? Or should it be defined […]

2025-07-07

Microbial Shift and Realignment Process (MSRP)

Overview The Microbial Shift and Realignment Process (MSRP) is the proprietary framework used to construct every microbiome signature in the Microbiome Signatures Database. It is designed to overcome the complexity, inconsistency, and heterogeneity of microbiome research by applying a structured, evidence-weighted approach to microbial pattern recognition and clinical translation. Rather than merely cataloging taxonomic associations, […]

2025-07-07

How Microbiome Signatures Are Derived

Overview The Microbiome Signatures Database curates condition-specific microbial patterns—referred to as microbiome signatures—through a structured and reproducible synthesis process that integrates evidence across the scientific literature. This methodology prioritizes clinical relevance, microbial consistency, and actionable insight. Overview of Methodology Each microbiome signature is constructed using the Microbial Shift and Realignment Process (MSRP), a proprietary framework […]

2025-06-16

Low‑Nickel Diet (LNiD)

A low-nickel diet (LNiD) is a therapeutic dietary intervention that eliminates high-nickel foods, primarily plant-based sources such as legumes, nuts, whole grains, and cocoa, to reduce systemic nickel exposure. It is clinically validated for managing systemic nickel allergy syndrome (SNAS) and nickel-induced eczema. Its relevance is well-established in microbiome modulation, with studies demonstrating clinical benefits in conditions such as endometriosis, fibromyalgia, irritable bowel syndrome, and GERD.

2025-06-15

Lugdunin

Lugdunin is a microbiome-derived cyclic peptide antibiotic with direct anti-S. aureus activity and host immune-boosting effects. It induces LL-37 and CXCL8, recruits immune cells, and synergizes with host peptides, making it a promising candidate for MRSA and atopic dermatitis interventions.